5-Hydroxytryptamine1A Receptor Responsivity in Obsessive-Compulsive Disorder
Authors:
- Angelika HohAHAngelika Hoh
- Jörg Disselkamp-TietzeJDJörg Disselkamp-Tietze
- Martin WiesmannMWMartin Wiesmann
- Michael OsterheiderMOMichael Osterheider
- Heinrich M. SchulteHSHeinrich M. Schulte
- 1 June 1991
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 48 (6) , 540-547
Abstract
• To evaluate 5-hydroxytryptamine1Areceptor responsivity in obsessive-compulsive disorder, we examined hypothermic, neuroendocrine, and behavioral responses to the selective 5-hydroxytryptamine1Areceptor ligand ipsapirone in patients with primary obsessive-compulsive disorder and healthy controls. Twelve patients and 22 controls received a single dose of ipsapirone, 0.3 mg/kg, or placebo under double-blind, random assignment conditions. Ipsapirone induced hypothermia and release of corticotropin and cortisol but had no effect on behavior, including obsessive or compulsive symptoms. Thermoregulatory and neuroendocrine responses to ipsapirone were not consistently different between healthy controls and patients with obsessive-compulsive disorder. These results provide no direct support for the hypothesis that a serotonergic dysfunction related to 5-hydroxytryptamine1Areceptors may be linked to the pathophysiologic characteristics of obsessive-compulsive disorder and point to the need for the evaluation of other 5-hydroxytryptamine receptor subtypes. Future studies of the responsivity of 5-hydroxytryptamine1Areceptors to direct-acting ligands, such as ipsapirone, should facilitate assessment of the integrity of the 5-hydroxytryptamine system and its involvement in antiobsessional drug effects.Keywords
This publication has 38 references indexed in Scilit:
- Psychobiologie der ZwangskrankheitFortschritte der Neurologie · Psychiatrie, 1991
- Effects of Serotonergic Agonists on Neuroendocrine Responses of Rhesus Monkeys and Patients with Depression and Anxiety Disorders1989
- Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findingsAmerican Journal of Psychiatry, 1988
- Serotonin and Mood: Neuroendocrine Aspects1988
- Treatment of severe obsessive-compulsive disorder with fluvoxamineAmerican Journal of Psychiatry, 1987
- Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiologyBiological Psychiatry, 1987
- Biochemical Changes During Clomipramine Treatment of Childhood Obsessive-Compulsive DisorderArchives of General Psychiatry, 1987
- High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patientsAmerican Journal of Psychiatry, 1986
- Obsessive-compulsive disorder and serotonin: Is there a connection?Biological Psychiatry, 1985
- Biological markers in obsessive-compulsive and affective disordersJournal of Psychiatric Research, 1984